Polycystic Ovarian Syndrome: Long-Term Health Consequences

Temeka Zore, Nikhil V. Joshi, Daria Lizneva, Ricardo Azziz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women and can be associated with significant adverse sequelae that can affect overall long-term health and well-being. This review provides a succinct but comprehensive overview of our current understanding concerning the known morbidities of PCOS, beginning with a review of the importance of the different phenotypes of PCOS in determining long-term morbidity, the confounding impact of obesity on health outcomes in PCOS, and the immediate short-term consequences of the disorder (including dermatologic, reproductive, and mood disturbances). The longer-term morbidities of PCOS are then reviewed including metabolic consequences (impaired glucose tolerance and type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease), dyslipidemia and vascular dysfunction (including hypertension and increased incidences of cerebrovascular accidents and thromboembolisms on oral contraceptives), neoplastic (primarily endometrial adenocarcinoma), and mental health disorders (including greater incidences of depressive and anxiety disturbances and psychosexual dysfunction). In conclusion, strategies for the prevention and amelioration of long-term morbidities in PCOS are presented.

Original languageEnglish (US)
Pages (from-to)271-281
Number of pages11
JournalSeminars in Reproductive Medicine
Volume35
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Polycystic Ovary Syndrome
Health
Morbidity
Psychological Sexual Dysfunctions
Glucose Intolerance
Thromboembolism
Incidence
Dyslipidemias
Oral Contraceptives
Mental Disorders
Type 2 Diabetes Mellitus
Blood Vessels
Mental Health
Adenocarcinoma
Anxiety
Obesity
Stroke
Hypertension
Phenotype

Keywords

  • anxiety
  • breast cancer
  • cardiovascular disease
  • depression
  • endometrial adenocarcinoma
  • health consequences
  • hypertension
  • metabolic dysfunction
  • polycystic ovarian syndrome
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Endocrinology
  • Obstetrics and Gynecology
  • Physiology (medical)

Cite this

Polycystic Ovarian Syndrome : Long-Term Health Consequences. / Zore, Temeka; Joshi, Nikhil V.; Lizneva, Daria; Azziz, Ricardo.

In: Seminars in Reproductive Medicine, Vol. 35, No. 3, 01.05.2017, p. 271-281.

Research output: Contribution to journalArticle

Zore, Temeka ; Joshi, Nikhil V. ; Lizneva, Daria ; Azziz, Ricardo. / Polycystic Ovarian Syndrome : Long-Term Health Consequences. In: Seminars in Reproductive Medicine. 2017 ; Vol. 35, No. 3. pp. 271-281.
@article{7b6521623b714bafa530240330a06890,
title = "Polycystic Ovarian Syndrome: Long-Term Health Consequences",
abstract = "Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women and can be associated with significant adverse sequelae that can affect overall long-term health and well-being. This review provides a succinct but comprehensive overview of our current understanding concerning the known morbidities of PCOS, beginning with a review of the importance of the different phenotypes of PCOS in determining long-term morbidity, the confounding impact of obesity on health outcomes in PCOS, and the immediate short-term consequences of the disorder (including dermatologic, reproductive, and mood disturbances). The longer-term morbidities of PCOS are then reviewed including metabolic consequences (impaired glucose tolerance and type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease), dyslipidemia and vascular dysfunction (including hypertension and increased incidences of cerebrovascular accidents and thromboembolisms on oral contraceptives), neoplastic (primarily endometrial adenocarcinoma), and mental health disorders (including greater incidences of depressive and anxiety disturbances and psychosexual dysfunction). In conclusion, strategies for the prevention and amelioration of long-term morbidities in PCOS are presented.",
keywords = "anxiety, breast cancer, cardiovascular disease, depression, endometrial adenocarcinoma, health consequences, hypertension, metabolic dysfunction, polycystic ovarian syndrome, type 2 diabetes mellitus",
author = "Temeka Zore and Joshi, {Nikhil V.} and Daria Lizneva and Ricardo Azziz",
year = "2017",
month = "5",
day = "1",
doi = "10.1055/s-0037-1603096",
language = "English (US)",
volume = "35",
pages = "271--281",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Polycystic Ovarian Syndrome

T2 - Long-Term Health Consequences

AU - Zore, Temeka

AU - Joshi, Nikhil V.

AU - Lizneva, Daria

AU - Azziz, Ricardo

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women and can be associated with significant adverse sequelae that can affect overall long-term health and well-being. This review provides a succinct but comprehensive overview of our current understanding concerning the known morbidities of PCOS, beginning with a review of the importance of the different phenotypes of PCOS in determining long-term morbidity, the confounding impact of obesity on health outcomes in PCOS, and the immediate short-term consequences of the disorder (including dermatologic, reproductive, and mood disturbances). The longer-term morbidities of PCOS are then reviewed including metabolic consequences (impaired glucose tolerance and type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease), dyslipidemia and vascular dysfunction (including hypertension and increased incidences of cerebrovascular accidents and thromboembolisms on oral contraceptives), neoplastic (primarily endometrial adenocarcinoma), and mental health disorders (including greater incidences of depressive and anxiety disturbances and psychosexual dysfunction). In conclusion, strategies for the prevention and amelioration of long-term morbidities in PCOS are presented.

AB - Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women and can be associated with significant adverse sequelae that can affect overall long-term health and well-being. This review provides a succinct but comprehensive overview of our current understanding concerning the known morbidities of PCOS, beginning with a review of the importance of the different phenotypes of PCOS in determining long-term morbidity, the confounding impact of obesity on health outcomes in PCOS, and the immediate short-term consequences of the disorder (including dermatologic, reproductive, and mood disturbances). The longer-term morbidities of PCOS are then reviewed including metabolic consequences (impaired glucose tolerance and type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease), dyslipidemia and vascular dysfunction (including hypertension and increased incidences of cerebrovascular accidents and thromboembolisms on oral contraceptives), neoplastic (primarily endometrial adenocarcinoma), and mental health disorders (including greater incidences of depressive and anxiety disturbances and psychosexual dysfunction). In conclusion, strategies for the prevention and amelioration of long-term morbidities in PCOS are presented.

KW - anxiety

KW - breast cancer

KW - cardiovascular disease

KW - depression

KW - endometrial adenocarcinoma

KW - health consequences

KW - hypertension

KW - metabolic dysfunction

KW - polycystic ovarian syndrome

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85021693520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021693520&partnerID=8YFLogxK

U2 - 10.1055/s-0037-1603096

DO - 10.1055/s-0037-1603096

M3 - Article

AN - SCOPUS:85021693520

VL - 35

SP - 271

EP - 281

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 3

ER -